Carcinoembryonic antigen as a predictor of treatment outcomes in cancer patients receiving immune checkpoint inhibitors
Objective Carcinoembryonic antigen (CEA) is a widely used tumor marker and is associated with traditional therapeutic efficacy. Our study aims to assess the predictive significance of baseline carcinoembryonic antigen (CEA) levels and CEA level changes on the efficacy of immune checkpoint inhibitors...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Annals of Medicine |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/07853890.2025.2531255 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|